| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0053 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0066 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0072 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.026 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |